Abstract
The modified U1 snRNA gene can suppress expression of a target transgene. In the present study, its potential utility to inhibit a dominant negative/gain of function mutation is explored. Using a green fluorescent protein (GFP) target gene, inhibition was achieved in all cells transduced with U1antiGFP directed at multiple sites within GFP. Using a chloramphenicol acetyltransferase (CAT) target gene, inhibition was not increased by increasing the hybridization domain from 10 to 16 bp or when a site in an upstream exon or intron was targeted. To determine if a U1 anti-target design could discriminate between two transcripts that differ by a 1-2 bp mismatch, GFPtpz and GFPsaph were chosen as targets because they share sequence homology except for three regions where a 1, 2 or 3 bp mismatch exists. The results demonstrated that U1antiGFP correctly reduced its cognate GFP expression by >90% and therefore U1 anti-target constructs are able to discriminate a 1 or 2 bp mismatch in their target mRNA. Thus, these U1 anti-target constructs may be effective in a strategy of somatic gene therapy for a dominant negative/gain of function mutation due to the discreteness of its discrimination. It may complement other anti-target strategies to reduce the cellular load of a mutant transcript.
Cite
CITATION STYLE
Liu, P., Gucwa, A., Stover, M. L., Buck, E., Lichtler, A., & Rowe, D. (2002). Analysis of inhibitory action of modified U1 snRNAs on target gene expression: Discrimination of two RNA targets differing by a 1 bp mismatch. Nucleic Acids Research, 30(11), 2329–2339. https://doi.org/10.1093/nar/30.11.2329
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.